Veru (VERU.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug12

Veru released FY2025 Q3 earnings on August 12 During-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5002 (forecast USD -0.5333)

20:00

Veru released FY2025 9 Months Earnings on August 12 During-Market EST with actual revenue USD 0 and actual EPS USD -1.6515

20:00

Aug5

Veru to Release FY2025 Q3 Earnings on August 12 During-Market EST, Forecast EPS USD -0.0533

00:07

Jul8

Veru Inc. Unveils Progress in Cardiometabolic Drug Pipeline

20:19

Jun24

Veru Inc. Reports Positive Clinical Trial Results for Enobosarm

12:36

Jun11

Veru Inc. to Participate in the 2025 BTIG Obesity Health Forum

12:52

Schedules & Filings

Schedules

Filings

Aug12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -7.333 M, EPS -0.5002

Aug11

Reverse Stock Split(EST)

1-for-10 Reverse Stock Split

May8

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.902 M, EPS -0.5397

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More